Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease

ObjectivesThe aim of this open-label study was to investigate the long-term safety and efficacy of selegiline as monotherapy in Japanese patients with early Parkinson disease (PD).MethodsWe conducted a 56-week prospective study in patients with early PD (N = 134) who had previously completed the ran